Quotes 5-day view Delayed London Stock Exchange
09/13/2021
09/14/2021
09/15/2021
09/16/2021
09/17/2021
Date
4908(c)
4950(c)
4870(c)
4976(c)
5130(c)
Last
267 489
285 866
138 228
184 445
1 430 634
Volume
-1.33% +0.86% -1.62% +2.18% +3.09% Change
Estimated financial data (e) GBP USD
Sales 2022
653 M 897 M 897 M
Net income 2022
65,5 M 90,0 M 90,0 M
Net Debt 2022
129 M 178 M 178 M
P/E ratio 2022
92,0x
Yield 2022
0,86%
Sales 2023
706 M 969 M 969 M
Net income 2023
80,5 M 111 M 111 M
Net Debt 2023
36,8 M 50,5 M 50,5 M
P/E ratio 2023
73,6x
Yield 2023
0,92%
Capitalization
5 552 M 7 636 M 7 627 M
EV / Sales 2022
8,70x
EV / Sales 2023
7,92x
Nbr of Employees
-
Free-Float
98,4%
Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals Research and Development. The European Pharmaceuticals Segment includes Dechra Veterinary Products Europe, Dechra...
Ratings of Dechra Pharmaceuticals PLC
All news about DECHRA PHARMACEUTICALS PLC
09/07 DECHRA PHARMACEUTICALS : JP Morgan Raises Dechra Pharmaceuticals PT, Keeps Overw..MT
09/07 DECHRA PHARMACEUTICALS : Liberum Boosts Dechra's PT, Affirms Sell RatingMT
09/06 GLOBAL MARKETS LIVE : Puma, Boeing, Holcim, Revolut, Amazon...09/06 ANALYST RECOMMENDATIONS : Asos, Best Buy, Docusign, Greif, Hewlett Packard...09/06 DECHRA PHARMACEUTICALS : 06 September 2021 Preliminary Results Presentation for ..PU
09/06 FTSE 100 to Open Higher After Upbeat Asia Trading DJ
09/06 DECHRA PHARMACEUTICALS : Boosts Final Dividend Amid FY21 Profit GrowthMT
09/06 DECHRA PHARMACEUTICALS : Earnings Flash (DPH.L) DECHRA PHARMACEUTICALS Reports F..MT
09/06 DECHRA PHARMACEUTICALS : Earnings Flash (DPH.L) DECHRA PHARMACEUTICALS Posts FY2..MT
09/06 Dechra Pharmaceuticals plc Reports Earnings Results for the Full Year Ended J.. CI
09/06 Dechra Pharmaceuticals PLC Proposes Final Dividend, Payable on November 19, 2.. CI
08/25 The latest from London : Morrisons to rally the FTSE 10008/25 Just Eat Takeaway.com to Lose Place in FTSE 100 Index in Latest Reshuffle DJ
08/25 FTSE : Morrisons set to enter FTSE 100 as M&A interest boost sharesRE
07/13 DECHRA PHARMACEUTICALS : JPMorgan Lifts Dechra's PT, Affirms Overweight RatingMT
News in other languages on DECHRA PHARMACEUTICALS PLC
Analyst Recommendations on DECHRA PHARMACEUTICALS PLC
Chart DECHRA PHARMACEUTICALS PLC
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends DECHRA PHARMACEUTICALS PLC
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
5 130,00 GBX
Average target price
4 914,44 GBX
Spread / Average Target
-4,20%
Please enable JavaScript in your browser's settings to use dynamic charts.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
